Skin Biopsy Market Information: By Type (Shave Biopsy, Excisional Biopsy, Incisional Biopsy), Device (Needle Based Biopsy Guns, Biopsy Forceps, Biopsy Needles), Indication (Cancer, Actinic Keratosis, Skin Infection), End User - Forecast till 2030
ID: MRFR/MED/3229-HCR | 110 Pages | Published By Kinjoll Dey on March 2023
Skin Biopsy Market Overview
The skin biopsy market is projected to reach USD 162.7 Million by 2030 at 9.89% CAGR during the forecast period 2022-2030.Skin biopsy is a procedure involving the removal of skin for examination and providing information about any disease or clinical conditions. It is performed to determine the presence of any cancerous cells or any type of skin diseases. Skin cancer, actinic keratosis, dermatitis, psoriasis, and skin infection are various diseases that can be diagnosed through skin biopsy. During the procedure, the sample taken from the affected or diseased part of the skin is placed in formaldehyde solution, the tissue is processed and then examined under the microscope.
Key Players in the Global Skin Biopsy Market
Some of the key players in skin biopsy market are Boston Scientific Corporation (U.S.), COOK Medical (U.S.), BD (U.S.), DTR Medical Ltd (U.K), Devicor Medical Products, Inc. part of Leica Biosystems. (U.S.), Gallini Srl (Italy), Hologic, Inc. (U.S.), and Cardinal Health (U.S.).
Segments
The global skin biopsy market is segmented on the basis of type, devices, indication, and end user.
On the basis of type, skin biopsy market is segmented into shave biopsy, punch biopsy, excisional biopsy and incisional biopsy.
On the basis of devices, the skin biopsy market is segmented into needle based biopsy guns, biopsy curettes and punches, guidance systems, biopsy forceps, biopsy needles and others.
On the basis of indication, the skin biopsy market is segmented into actinic keratosis, dermatitis, psoriasis, skin infection, cancer, and others.
Skin infection is further segmented into viral infections, deep fungal infections, basal cell carcinoma, squamous cell carcinoma, and melanoma.
On the basis of end user, the market is segmented into hospitals, dermatology clinics, and others.
Regional Analysis of the Global Skin Biopsy Market
America secures a leading position in the market for skin biopsy owing to the rising prevalence of skin diseases and cancer in the U.S. and presence of key market players. According to the American Academy of Dermatology (AAD), skin diseases affects one in every fourth American. The prevalence of skin diseases is also found to be increasing in Canada.
Europe is the second largest market for skin biopsy. Increasing prevalence of skin diseases such as fungal infections, and dermatitis, and increasing demand for technological advanced diagnostic services further drive the market growth.
The skin biopsy market in Asia Pacific is expected to grow at the fastest pace and is driven by the rising geriatric population, rising prevalence of skin cancer, and increasing number of biopsies performed in the hospitals.
The Middle East & Africa also show a steady rise in the skin biopsy market owing to increasing prevalence of diabetes and other chronic diseases
Intended Audience
- Biopsy Devices Manufacturers
- Biopsy Devices Suppliers
- Private Research Laboratories
- Research and Development (R&D) Companies
- Market Research and Consulting Service Providers
- Government Research Laboratories
Report Scope:
| Report Attribute/Metric | Details |
|---|---|
| Market Size | 2030: USD 162.7 Million |
| CAGR | 2022-2030: 9.89% |
| Base Year | 2021 |
| Forecast Period | 2030 |
| Historical Data | 2020 |
| Forecast Units | Value (USD Million) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Type, Devices, Indication, And End User |
| Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Key Vendors | Boston Scientific Corporation (U.S.), COOK Medical (U.S.), BD (U.S.), DTR Medical Ltd (U.K), Devicor Medical Products, Inc. part of Leica Biosystems. (U.S.), Gallini Srl (Italy), Hologic, Inc. (U.S.), and Cardinal Health (U.S.) |
| Key Market Opportunities | Rising expenditure on the medical devices and instruments |
| Key Market Drivers |
|
Frequently Asked Questions (FAQ) :
Skin biopsy market is projected to grow at approximately 9.89% CAGR during the assessment period (2022-2030).
Increasing prevalence of skin diseases, rising awareness about skin cancer & its treatment, and growing demand for technologically advanced medical devices, are the major tailwinds pushing the growth of the global skin biopsy market.
High cost of treatment for skin diseases is a major growth impeder for the global skin biopsy market.
North America holds the largest share in the global skin biopsy market, followed by Europe and the Asia Pacific, respectively.
COOK Medical (U.S.), Boston Scientific Corporation (U.S.), BD (U.S.), Devicor Medical Products, Inc. part of Leica Biosystems. (U.S.), DTR Medical Ltd (U.K), Gallini Srl (Italy), Cardinal Health (U.S.), and Hologic, Inc. (U.S.), are some of the top players operating in the global skin biopsy market.
